US Stock MarketDetailed Quotes

Traws Pharma (TRAW)

Watchlist
  • 1.720
  • -0.050-2.82%
Close Jan 15 16:00 ET
  • 1.790
  • +0.070+4.07%
Post 18:18 ET
13.74MMarket Cap-0.95P/E (TTM)

Traws Pharma (TRAW) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
4,694.74%2.73M
1.79%57K
0.00%226K
0.00%56K
0.00%57K
0.00%57K
0.00%56K
0.00%226K
0.00%56K
Operating revenue
--0
4,694.74%2.73M
1.79%57K
0.00%226K
0.00%56K
0.00%57K
0.00%57K
0.00%56K
0.00%226K
0.00%56K
Cost of revenue
Gross profit
Operating expense
-52.81%4.06M
-32.97%3.98M
-0.15%5.26M
22.47%25.14M
18.06%5.33M
66.98%8.59M
27.30%5.94M
-14.94%5.27M
3.38%20.52M
-21.97%4.52M
Selling and administrative expenses
-49.89%1.74M
-14.47%1.69M
-17.94%2.75M
35.13%12.29M
66.79%3.48M
29.56%3.48M
-10.58%1.98M
58.83%3.36M
7.66%9.09M
3.32%2.08M
-General and administrative expense
-49.89%1.74M
-14.47%1.69M
-17.94%2.75M
35.13%12.29M
66.79%3.48M
29.56%3.48M
-10.58%1.98M
58.83%3.36M
7.66%9.09M
3.32%2.08M
Research and development costs
-54.80%2.31M
-42.20%2.29M
31.07%2.51M
12.40%12.85M
-23.66%1.86M
107.85%5.11M
61.40%3.96M
-53.14%1.91M
0.21%11.43M
-35.49%2.43M
Operating profit
52.50%-4.06M
78.77%-1.25M
0.17%-5.2M
-22.72%-24.91M
-18.29%-5.28M
-67.73%-8.54M
-27.64%-5.88M
15.07%-5.21M
-3.42%-20.3M
22.18%-4.46M
Net non-operating interest income expense
Other net income (expense)
52.46%93K
100.28%334K
11,556.33%26.69M
-10,589.85%-141.61M
-8,964.75%-24.64M
-82.57%61K
-32,671.94%-117.26M
-36.74%229K
103.62%1.35M
-11.46%278K
Gain on sale of security
---3K
--146K
--26.51M
---24.44M
----
----
----
----
----
----
Special income (charges)
--0
--0
----
---117.46M
--0
--0
---117.46M
----
--0
--0
-Less:Other special charges
----
----
----
--117.46M
--0
----
--117.46M
----
----
----
Other non- operating income (expenses)
57.38%96K
-8.29%188K
-21.40%180K
-78.59%289K
-174.10%-206K
-82.57%61K
-43.06%205K
-36.74%229K
103.62%1.35M
-11.46%278K
Income before tax
53.25%-3.96M
99.26%-915K
531.27%21.49M
-778.84%-166.52M
-615.15%-29.92M
-78.84%-8.48M
-2,797.48%-123.14M
13.71%-4.98M
0.08%-18.95M
22.80%-4.18M
Income tax
Net income
53.25%-3.96M
99.26%-915K
531.27%21.49M
-778.84%-166.52M
-615.15%-29.92M
-78.84%-8.48M
-2,797.48%-123.14M
13.71%-4.98M
0.08%-18.95M
22.80%-4.18M
Net income continuous Operations
53.25%-3.96M
99.26%-915K
531.27%21.49M
-778.84%-166.52M
-615.15%-29.92M
-78.84%-8.48M
-2,797.48%-123.14M
13.71%-4.98M
0.08%-18.95M
22.80%-4.18M
Minority interest income
Net income attributable to the parent company
53.25%-3.96M
99.26%-915K
531.27%21.49M
-778.84%-166.52M
-615.15%-29.92M
-78.84%-8.48M
-2,797.48%-123.14M
13.71%-4.98M
0.08%-18.95M
22.80%-4.18M
Preferred stock dividends
86.84%-927K
99.72%-290K
-111.85M
-8.5M
-7.04M
-102.37M
Other preferred stock dividends
Net income attributable to common stockholders
-111.79%-3.04M
96.99%-625K
531.27%21.49M
-188.55%-54.67M
-411.93%-21.42M
69.76%-1.43M
-388.80%-20.77M
13.71%-4.98M
0.08%-18.95M
22.80%-4.18M
Basic earnings per share
77.18%-0.34
99.46%-0.11
136.66%2.17
-56.00%-35.21
-17.81%-5.867
73.58%-1.49
-310.40%-20.52
15.43%-5.92
0.79%-22.57
23.38%-4.98
Diluted earnings per share
77.18%-0.34
99.46%-0.11
135.30%2.09
-56.00%-35.21
-17.81%-5.867
73.58%-1.49
-310.40%-20.52
15.43%-5.92
0.79%-22.57
23.38%-4.98
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 04,694.74%2.73M1.79%57K0.00%226K0.00%56K0.00%57K0.00%57K0.00%56K0.00%226K0.00%56K
Operating revenue --04,694.74%2.73M1.79%57K0.00%226K0.00%56K0.00%57K0.00%57K0.00%56K0.00%226K0.00%56K
Cost of revenue
Gross profit
Operating expense -52.81%4.06M-32.97%3.98M-0.15%5.26M22.47%25.14M18.06%5.33M66.98%8.59M27.30%5.94M-14.94%5.27M3.38%20.52M-21.97%4.52M
Selling and administrative expenses -49.89%1.74M-14.47%1.69M-17.94%2.75M35.13%12.29M66.79%3.48M29.56%3.48M-10.58%1.98M58.83%3.36M7.66%9.09M3.32%2.08M
-General and administrative expense -49.89%1.74M-14.47%1.69M-17.94%2.75M35.13%12.29M66.79%3.48M29.56%3.48M-10.58%1.98M58.83%3.36M7.66%9.09M3.32%2.08M
Research and development costs -54.80%2.31M-42.20%2.29M31.07%2.51M12.40%12.85M-23.66%1.86M107.85%5.11M61.40%3.96M-53.14%1.91M0.21%11.43M-35.49%2.43M
Operating profit 52.50%-4.06M78.77%-1.25M0.17%-5.2M-22.72%-24.91M-18.29%-5.28M-67.73%-8.54M-27.64%-5.88M15.07%-5.21M-3.42%-20.3M22.18%-4.46M
Net non-operating interest income expense
Other net income (expense) 52.46%93K100.28%334K11,556.33%26.69M-10,589.85%-141.61M-8,964.75%-24.64M-82.57%61K-32,671.94%-117.26M-36.74%229K103.62%1.35M-11.46%278K
Gain on sale of security ---3K--146K--26.51M---24.44M------------------------
Special income (charges) --0--0-------117.46M--0--0---117.46M------0--0
-Less:Other special charges --------------117.46M--0------117.46M------------
Other non- operating income (expenses) 57.38%96K-8.29%188K-21.40%180K-78.59%289K-174.10%-206K-82.57%61K-43.06%205K-36.74%229K103.62%1.35M-11.46%278K
Income before tax 53.25%-3.96M99.26%-915K531.27%21.49M-778.84%-166.52M-615.15%-29.92M-78.84%-8.48M-2,797.48%-123.14M13.71%-4.98M0.08%-18.95M22.80%-4.18M
Income tax
Net income 53.25%-3.96M99.26%-915K531.27%21.49M-778.84%-166.52M-615.15%-29.92M-78.84%-8.48M-2,797.48%-123.14M13.71%-4.98M0.08%-18.95M22.80%-4.18M
Net income continuous Operations 53.25%-3.96M99.26%-915K531.27%21.49M-778.84%-166.52M-615.15%-29.92M-78.84%-8.48M-2,797.48%-123.14M13.71%-4.98M0.08%-18.95M22.80%-4.18M
Minority interest income
Net income attributable to the parent company 53.25%-3.96M99.26%-915K531.27%21.49M-778.84%-166.52M-615.15%-29.92M-78.84%-8.48M-2,797.48%-123.14M13.71%-4.98M0.08%-18.95M22.80%-4.18M
Preferred stock dividends 86.84%-927K99.72%-290K-111.85M-8.5M-7.04M-102.37M
Other preferred stock dividends
Net income attributable to common stockholders -111.79%-3.04M96.99%-625K531.27%21.49M-188.55%-54.67M-411.93%-21.42M69.76%-1.43M-388.80%-20.77M13.71%-4.98M0.08%-18.95M22.80%-4.18M
Basic earnings per share 77.18%-0.3499.46%-0.11136.66%2.17-56.00%-35.21-17.81%-5.86773.58%-1.49-310.40%-20.5215.43%-5.920.79%-22.5723.38%-4.98
Diluted earnings per share 77.18%-0.3499.46%-0.11135.30%2.09-56.00%-35.21-17.81%-5.86773.58%-1.49-310.40%-20.5215.43%-5.920.79%-22.5723.38%-4.98
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More